Promising news for peanut allergy sufferers
The results of two separate studies emerged during March showing the controlled reintroduction of peanut in sensitive individuals produced a 70% and 80% reduction in peanut allergy. These are significant and exciting results for what has been understood to be a life-long allergy.
The latter study by Dr Mimi Tang and colleagues in Melbourne combined 18 months of oral immunotherapy (minute amounts of peanut given daily) with probiotics.
A free full text version of the article can be accessed via the New England Journal of Medicine website.
It should be noted that unsupervised oral therapy carries significant safety concerns e.g. anaphylaxis. Please discuss with your doctor.